| Metric | Q2'26 | Q3'26 | Change |
|---|---|---|---|
| Total Sales | $2.04B, +15% YoY | $2.22B, +17% YoY | Accelerating, record quarter |
| Organic Sales Growth | +10% | +10% | Flat, holding at double digits |
| Diluted EPS | $2.09, +17% | $2.21, +17% | Same growth rate, beat guidance again |
| Overall Orders Growth | +28% YoY | +35% YoY | Accelerating on headline, but M&A-driven |
| Organic Orders Growth | +25% | +17% | -800bps deceleration, the real signal |
| Backlog | $4.11B | $4.54B, +27% from year start | Record, still building |
| Operating Margin | 26.6%, +60bps | 26.8%, +60bps | Stable expansion pace |
| Core Margin | 27.1%, +110bps | 27.3%, +110bps | Identical bps expansion |
| EMG Core Margin | 26.2%, +290bps | 27.5%, +210bps | Still strong but decelerating bps gain |
| Free Cash Flow | $452M, +37%, 111% conversion | $527M, +26%, 124% conversion | Growth rate decelerated, conversion improved |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.